1. Home
  2. CNTA vs LNN Comparison

CNTA vs LNN Comparison

Compare CNTA & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • LNN
  • Stock Information
  • Founded
  • CNTA 2020
  • LNN 1954
  • Country
  • CNTA United Kingdom
  • LNN United States
  • Employees
  • CNTA 86
  • LNN N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • LNN Industrial Machinery/Components
  • Sector
  • CNTA Health Care
  • LNN Industrials
  • Exchange
  • CNTA Nasdaq
  • LNN Nasdaq
  • Market Cap
  • CNTA 1.6B
  • LNN 1.5B
  • IPO Year
  • CNTA 2021
  • LNN 1988
  • Fundamental
  • Price
  • CNTA $12.43
  • LNN $135.94
  • Analyst Decision
  • CNTA Strong Buy
  • LNN Hold
  • Analyst Count
  • CNTA 11
  • LNN 1
  • Target Price
  • CNTA $27.00
  • LNN $128.00
  • AVG Volume (30 Days)
  • CNTA 1.2M
  • LNN 88.5K
  • Earning Date
  • CNTA 08-12-2025
  • LNN 06-26-2025
  • Dividend Yield
  • CNTA N/A
  • LNN 1.07%
  • EPS Growth
  • CNTA N/A
  • LNN 12.44
  • EPS
  • CNTA N/A
  • LNN 7.03
  • Revenue
  • CNTA $15,000,000.00
  • LNN $647,542,000.00
  • Revenue This Year
  • CNTA N/A
  • LNN $11.97
  • Revenue Next Year
  • CNTA N/A
  • LNN $1.57
  • P/E Ratio
  • CNTA N/A
  • LNN $19.19
  • Revenue Growth
  • CNTA 118.88
  • LNN 0.46
  • 52 Week Low
  • CNTA $8.46
  • LNN $109.27
  • 52 Week High
  • CNTA $19.09
  • LNN $144.08
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 47.36
  • LNN 49.37
  • Support Level
  • CNTA $11.77
  • LNN $133.12
  • Resistance Level
  • CNTA $13.06
  • LNN $136.83
  • Average True Range (ATR)
  • CNTA 0.70
  • LNN 2.52
  • MACD
  • CNTA 0.03
  • LNN -0.57
  • Stochastic Oscillator
  • CNTA 51.21
  • LNN 25.76

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

About LNN Lindsay Corporation

Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: